How can we make iPSC-derived therapies both efficacious and cost-effective for large-scale application? 🌟 Spotlight on iPSC-Based Therapies: A Roundtable You Won’t Want to Miss! 🌟 Join Ramzey Abujarour, Executive Director - iPSC Science and Manufacturing at Fate Therapeutics Inc. on 25th February 2025, from 09:05 - 10:05 during the Cell Therapy Development Track at the Advanced Therapies Xchange - San Diego - 2025, for an in-depth discussion on this transformative topic. 🔍 Key Discussion Points: 1️⃣ Developing stealth mechanisms to enhance the persistence of allogeneic therapies, including iPSC-based treatments. 2️⃣ Strategies to improve the manufacturability, scalability, and cost-effectiveness of iPSC-based therapies. 3️⃣ Effective methods for characterizing engineered iPSC-based therapies to ensure therapeutic success. 💡 About Ramzey Abujarour: Dr. Abujarour leads the iPSC Science and Manufacturing team at Fate Therapeutics, driving advancements in cGMP cell banking and iPSC technology. With a PhD in Molecular and Cell Biology from the University of Texas at Dallas, and experience as a researcher at The Scripps Research Institute and the Genomics Institute of the Novartis Research Foundation, Dr. Abujarour is at the forefront of iPSC innovation. 🎯 Don’t miss this opportunity to explore the latest advancements and challenges in iPSC-derived therapies with one of the field’s leading experts! 🔗 Register now to secure your place: https://lnkd.in/d2Q9Mj92 💊 Only for Senior Scientists and above, from Bio and Pharma companies with a drug pipeline. 💊 #iPSCTherapies #CellTherapyInnovation #AdvancedTherapies2025 #StemCellResearch #Biomanufacturing #ScalableTherapies #BiotechLeadership #FateTherapeutics #NextGenMedicine #AllogeneicTherapies #RegenerativeMedicine #TherapeuticDevelopment #CostEffectiveHealthcare #BiotechAdvancements #EngineeredTherapies #hubXchange #Xchanges #Roundtable #RegisterNow
